# OnCo record paper-cd47-colorectal-cancer-res-commun-2025 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-cd47-colorectal-cancer-res-commun-2025/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-cd47-colorectal-cancer-res-commun-2025" ;
  schema:name "Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer"@en ;
  schema:description "Phase 2 or 3 results paper on CD47 in Colorectal cancer, in Cancer research communications (2025), one of the most cited Europe PMC records with CD47 in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-cd47-colorectal-cancer-res-commun-2025/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/2767-9764.crc-25-0332>, <https://pubmed.ncbi.nlm.nih.gov/41171165/>, <https://europepmc.org/article/MED/41171165> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1158/2767-9764.crc-25-0332> ;
  schema:datePublished "2025"^^xsd:gYear ;
  schema:author "Lentz RW, Lang J, Pitts TM, et al." ;
  onco:journals <https://onco.cc/journals/cancer-research-communications/> .
